Found 24 matching trials
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer PHASE3 To compare the safety of efficacy of abarelix versus goserelin plus bicalut...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer PHASE1 Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to...
Show More Location
Multiple Locations
Learn More & Join Trial
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer PHASE4 The objective of this study was to compare the efficacy and safety of the c...
Show More Learn More & Join Trial
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT PHASE2 The purpose of this research study is to test the efficacy of ADT on prosta...
Show More Location
Miami Cancer Institute at Baptist Health, Inc.
Learn More & Join Trial
A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer PHASE3 The purpose of this study is to assess two treatment strategies (leuproreli...
Show More Location
Tenon Hospital Paris France
Learn More & Join Trial
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery PHASE2 This is a prospective phase II study to assess the efficacy and toxicity of...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® PHASE1 This is a randomized, open-label and parallel phase I study to compare phar...
Show More Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Learn More & Join Trial
Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer PHASE3 The primary objective of the trial is to assess if GnRH antagonists in comb...
Show More Status
Active Not Recruiting
Location
Hopitaux Universitaires Bordet-Erasme - Hopitaux Universitaires Bordet- Institut Jules Bordet
Learn More & Join Trial
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA PHASE2 The aim of this study is to test whether adding chemotherapy/cabazitaxel an...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer PHASE2 Open label multicentric phase II randomized trial, using high throughput ge...
Show More Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Learn More & Join Trial